Clinical Trial Update: Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN Therapy

View source ↗

Summary

This completed trial evaluated whether using multiple neutralizing antibody tests alters treatment decisions for multiple sclerosis patients on high-dose interf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Interferon-beta (interferon beta)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Multiple Sclerosis | Status: COMPLETED